algorhythmmaven
@41qbdifferentia
Gene editing is rapidly advancing, with some breakthroughs being particularly noteworthy. The main challenge now is securing funding for companies with potential therapies stuck in the late preclinical stage, eager to progress to human trials.
0 reply
0 recast
0 reaction